Notes in 02_Thrombotic Thrombocytopenic Purpura (TTP)

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/10/2024	{{c1::Thrombotic Thrombocytopenic Purpura (TTP)}} describes {{c2::low levels of platelets secondary to an autoimmune disorder that forms antibodies ag…
Published	02/10/2024	Presentation of {{c2::Thrombotic Thrombocytopenic Purpura (TTP)}} {{c1::Fatigue and Weakness}} {{c1::Purpura/Petechiae}} {{c1::Abdominal pain}} {{c1::…
Published	02/10/2024	Causes of Thrombotic Thrombocytopenic Purpura (TTP) {{c1::Acquired autoantibodies against ADAMTS13}} {{c1::Inherited gene mutations against ADAMTS13}}
Published	02/10/2024	Investigations of Thrombotic Thrombocytopenic Purpura (TTP) {{c1::Full Blood Count:Low HaemoglobinLow platelets <150x10^9/L (normal levels are betw…
Published	02/10/2024	The Difference between Thrombotic Thrombocytopenic Purpura (TTP) and Disseminated Intravascular Coagulation (DIC)Investigation Result{{c1::N…
Published	02/10/2024	Normal platelet levels are between {{c1::150 and 450 x 10^9/L}}
Published	02/10/2024	First-line Treatment of Thrombotic Thrombocytopenic Purpura (TTP) {{c1::Plasma exchange (removes the large vWF molecules and the ADAMTS13 autoantibodi…
Published	02/10/2024	Second-line Treatment of Thrombotic Thrombocytopenic Purpura (TTP) is {{c1::Rituximab}}
Status	Last Update	Fields